Effects of Comorbidities and Family History of Hypertension on Antihypertensive Treatment Adherence
DOI:
https://doi.org/10.30442/ahr.1102-02-278Keywords:
Antihypertensive treatment, Comorbidities, Family history, Hypertension, Treatment adherenceAbstract
Background: Treatment adherence is the sine qua non to optimal treatment outcome in managing chronic illnesses.
Objective: To determine the effects of comorbidities and family history of hypertension on treatment adherence among patients receiving antihypertensive care.
Methods: This study utilised a quasi-experimental design where 290 patients with hypertension responded to a questionnaire comprising 14 items of the Hill-bone Compliance High Blood Pressure Therapy Scale (Cronbach's alpha = 0.70).
Results: The results showed that treatment adherence was not significantly different for individuals with a family history of hypertension (F = 0.32, p = 0.720) and those with comorbidities (F = 0.62, p>0.05). However, a significant interaction between family history and comorbidity was observed (F = 6.338, p = 0.002), as adherence appeared to be better where patients had comorbidities and knew there was a positive family history of hypertension than where patients reported the absence of a family history of hypertension. Additionally, older adults showed significantly better adherence than younger adults (F = 3.38, p = 0.035), but no significant gender difference in treatment adherence was found (t = 0.78, p = 0.217).
Conclusion: The combined effects of comorbidities and family history of hypertension improved adherence to antihypertensive treatment. Information about comorbidities and family history can help patients develop a proper understanding and health beliefs to enhance treatment adherence.
References
1. Fernandez-Lazaro CI, Garcia-Gonzalez JM, Adams DP, Fernandez-Lazaro D, Mielgo-Ayuso J, Caballero-Garcia A, et al. Adherence to treatment and related factor among patients with chronic conditions in primary care: A cross-sectional study. BMC Family Practice 2019;20:132. https://doi.org/10.1186/s12875-019-1019-3
2. Gast A, Mathes T. Medication adherence influencing factors – an (updated overview of systematic reviews. Syst Rev 2019;8:112. https://doi.org/10.1186/s13643-019-1014-8
3. Hamrahian SM, Maarouf OH, Fulop T. A critical review of medication adherence in hypertension: Barriers and facilitators clinicians should consider. Patient Prefer Adherence 2022;16:2749-2757. https://doi.org/10.2147/PPA.S368784
4. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: Its importance in cardiovascular outcomes. Circulation, 2009;119:3028 – 3035. https://doi.org/10.1161CIRCULATIONHA.108.768986
5. Yuvaraj K, Gokul S, Sivaranjini K, Manikandanesan S, Murali S, Surendran G, Majella MG, et al. Prevalence of medication adherence and its associated factors among patients with non-communicable disease in rural Puducherry, South India - A facility-based cross-sectional study. J Fam Med Primary Scare 2019;8:701–705. https://doi.org/10.4103/jfmpc.jfmpc_350_18
6. Foley L, Larkin J, Lombard-Vance R, Murphy AW, Hynes L, Galvin E, et al. Prevalence and predictors of medication non-adherence among people living with multi-morbidity: A systematic review and meta-analysis. BMJ Open 2021;11:e044987. https://doi.org/10.1136/bmjopen-2020-044987
7. Martin-Fernandez J, Alonso-Safont T, Polentinos-Castro E, Esteban-Vasallo MD, Ariza-Cardiel G, González-Anglada MI, et al. Impact of hypertension diagnosis on morbidity and mortality: A retrospective cohort study in primary care. BMC Primary Care 2023;24:79. https://doi.org/10.1186/s12875-023-02036-2
8. Zhou D, Xi B, Zhao M, Wang L, Veeranki SP. Uncontrolled hypertension increases risk of all-cause and cardiovascular disease mortality in US adults: The NHANES III linked mortality study. Science Rep 2018;8:9418. https://doi.org/10.1038/s41598-018-27377-2.
9. Stentzel U, van den Berg N, Schulze LN, Schwaneberg T, Radicke F, Langosch JM, et al. Predictors of medication adherence among patients with severe psychiatric disorders: findings from the baseline assessment of a randomized controlled trial (Tecla). BMC Psychiatry 2018;18:155. https://doi.org/10.1186/s12888-018-1737-4.
10. Misdrahi D, Dupuy M, Dansou Y, Boyer L, Berna F, Capdevielle D, et al. Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: Insights from the multicentric FACE-SZ dataset. Trans Psychiatry 2023;13:341. https://doi.org/10.1038/s41398-023-02640-x
11. Tiyou A, Belachew TI, Alemseged F, Biadgilign S. Predictors of adherence to antiretroviral therapy among people living with HIV/AIDS in resource-limited setting of southwest Ethiopia. AIDS Res Ther 2010;7:39. https://doi.org/10.1186/1742-6405-7-39
12. Omezzine RG, Akkara A, Afifa AK, Asma BS, Rdissi A, Amamou K. Predictors of poor adherence to hypertension treatment. La Tunisie Medicale 2019;97:564-571.
13. Nikolic A, Djuric S, Biocanin V, Djordjevic K, Ravic M, Stojanovic A, et al. Predictors of non-adherence to medications in hypertensive patients. Iran J Public Health 2023;52:1181–1189. https://doi.org/10.18502/ijph.v52i612960.
14. Azeez IA, Akinyemi JO. Predictors of adherence to hypertension treatment among adult patients attending medical out-patient clinics of a secondary health care facility in Southwestern Nigeria. Afr J Med Med Sci 2019;48:483–491.
15. Brown R, Thorsteinsson E. Comorbidity: What is it and why is it important? In Brown R and Thorsteinsson E (Eds), Comorbidity: Symptoms, conditions, behaviour and treatments. Palgrave Macmillan/Springer Nature. 2020. pp.1-22. https://doi.org/10.1007/978-3-030-32545-9_1
16. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med 2009;7:357-63. https://doi.org/10.1370/afm.983
17. Saadat Z, Mikdoust F, Aerab-Sheibani H, Bahremand M, Shobiri E, Saadat H, et al. Adherence to antihypertensives in patients with comorbid conditions. Nephrourol Monthly 2015;7:e29863.
18. Etheridge JC, Sinyard RD, Brindle, ME. Chapter 90 – Implementation research. In Handbook for Designing and Conducting Clinical and Translational Research, Translational Surgery, Academic Press. 2023. pp.563–573. https://doi.org/10.1016/B978-0-323-90300-4.00043-4
19. Gan Q, Yu R, Lian Z, Yuan Y, Li Yuanping, Zheng L. Unravelling the link between hypertension and depression in older adults: A meta-analysis. Frontiers in Public Health 2023;11:130241. https://doi.org/10.3389/fpubh.2023.1302341
20. Ranasinghe P, Cooray DN, Jayawardena R, Katulanda P. The influence of family history of hypertension on disease prevalence and associated metabolic risk factors among Sri Lankan adults. BMC Public Health 2015;15:576. https://doi.org/10.1186/s12889-015-1927-7
21. Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy scale. Prog Cardiovasc Nurs 2000;15:90-96. https://doi.org/10.1111/j.1751-7117.2000.tb00211.x
22. Saadat Z, Nikdoust F, Aerab-Sheibani H, Bahremand M, Shobeiri E. Adherence to antihypertensives in patients with comorbid condition. Nephro-Urol 2015;7:e2986 https://doi.org/10.5812/numonthly.29863.
23. Allaham KK, Feyasa MB, Govender RD, Musa AMA, AlKaabi AJ, ElBarazi I, et al. Medication adherence among patients with multimorbidity in the United Arab Emirates. Patient Preference Adherence 2022;16:1187–1200. https://doi.org/10.2147/PPA.S355891
24. Arukala P. Impact of comorbidities on medication adherence in hypertensive patients. Value Health 2016;19:A615. https://doi.org/10.1016/j.jval.2016.09.1546
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Annals of Health Research (The Journal of the Medical and Dental Consultants Association of Nigeria, OOUTH, Sagamu, Nigeria)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The articles and other materials published in the Annals of Health Research are protected by the Nigerian Copyright laws. The journal owns the copyright over every article, scientific and intellectual materials published in it. However, the journal grants all authors, users and researchers access to the materials published in the journal with the permission to copy, use and distribute the materials contained therein only for academic, scientific and non-commercial purposes.
